E Fund Management (HK)’s Biogen BIIB Stock Holding History

E Fund Management (HK)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.7K	Buy	133 +38	+40%	+$7.27K	0.01%	243
2026 Q1	$17.4K	Buy	95 +78	+459%	+$14.4K	0.01%	222
2025 Q4	$3.04K	Sell	17 -82	-83%	-$13.4K	﹤0.01%	247
2025 Q3	$13.9K	Buy	99 +59	+148%	+$7.97K	0.01%	148
2025 Q2	$5.02K	Hold	40	–	–	﹤0.01%	144
2025 Q1	$5K	Buy	40 +30	+300%	+$4.29K	﹤0.01%	148
2024 Q4	$2K	Buy	10 +9	+900%	+$1.52K	﹤0.01%	154
2024 Q3	$0	Hold	1	–	–	﹤0.01%	128
2024 Q2	$0	Buy	+1	New	+$217	﹤0.01%	104

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

NGM

North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

CIM

Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

E Fund Management (HK)'s BIIB Position: Q2 2026 in Review

E Fund Management (HK) increased its Biogen (BIIB) stake by 40% in Q2 2026, buying an estimated $7.27K and bringing the position to 133 shares worth $28.7K. The position accounts for 0.01% of the portfolio, ranked #243.

E Fund Management (HK) first reported a position in BIIB in Q2 2024 and has held it in 9 quarters since. 205 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

E Fund Management (HK) held 133 shares of Biogen worth $28.7K as of Q2 2026.
E Fund Management (HK) bought 38 Biogen shares in Q2 2026, an estimated $7.27K.
Biogen made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #243 holding.
E Fund Management (HK) first reported a position in Biogen in Q2 2024 and has held it in 9 quarters since.
205 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.